Objective
Pharmacology Discovery Services, a contract research organization (CRO), seeks a Ph.D. scientist with two years of academic, industry or postdoctoral experience to manage in vivo inflammation / immunology and animal pharmacology projects. Our Taiwan facility has provided pharmacology testing services to the pharmaceutical industry for over 50 years including GI, metabolic disease, inflammation, immunology and autoimmune services for the discovery and development of novel anti-inflammatory agents. We continually expand our portfolio of in vivo inflammation / immunology services, including GI, metabolic disease, inflammation, and immunology models, as well as humanized models. We are seeking a qualified scientist to lead the innovation project, including rodent model and related ex vivo assay establishments. This position is for a Ph.D. scientist in pharmaceutical science, immunology, biology, biochemistry and molecular biology, or a relevant field to serve as a scientist and program coordinator for our in vivo inflammation team.
Job Description
The successful candidate will be responsible for marketing survey, and in vivo inflammation / immunology models and ex vivo innovations. The scientist will identify procedures from published literature, perform method optimization and troubleshooting to develop new testing procedures. The successful candidate will have strong project management, and team leadership skills, and need to be comfortable writing about in vivo inflammation / immunology projects and animal studies in English.
Plan and coordinate R&D projects to develop GI, metabolic disease, inflammation, and immunology models including allocation of study materials and resources.
Communicate study developments and data internally and externally to sponsors and generating study reports and presentations.
Author technical protocols, reports, and SOPs, in English, of study methods and the analysis and interpretation in vivo inflammation study data.
Manage multiple projects and deliverables and assign priorities.
Required skills
Independent research with in-lab expertise working with GI, metabolic disease, inflammation, and autoimmune models, including, IBD, diabetes, obesity, NASH, lupus, EAE, arthritis, dermatitis, fibrosis, and humanized models.
Education/Experience:
Ph. D. in Pharmaceutical Science, immunology, biology, biochemistry, and molecular biology with at least 2 years academic, industry experience or postdoctoral experience
We support your development! Do you feel you don’t match 100% of the requirements? Don’t hesitate to apply anyway! Eurofins companies are committed to supporting your career development.
We embrace diversity! Eurofins network of companies believe in strength and innovation through diversity, being an Equal Opportunity Employer. We prohibit discrimination against employees or applications based on gender identity and/or expression, race, nationality, age, religion, sexual orientation, disability, and everything else that makes employees of Eurofins companies unique.
Sustainability matters to us! We are well on our way to achieving our objective of carbon neutrality by 2025, through a combination of emission reduction and compensation initiatives. We encourage our laboratory leaders to make sustainable changes at their local level, and in addition to their initiatives we also count on our dedicated carbon reduction team to help us to achieve this goal!
Find out more in our career page: https://careers.eurofins.com/
Company description: Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier and more sustainable. From the food you eat, to the water you drink, to the medicines you rely on, Eurofins laboratories work with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate.
The Eurofins network of companies is the global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services. It is one of the market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and in the support of clinical studies, as well as having an emerging global presence in Contract Development and Manufacturing Organisations. It also has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing and in-vitro diagnostic products.
In over 35 years, Eurofins has grown from one laboratory in Nantes, France to 61,000 staff across a decentralised and entrepreneurial network of ca. 900 laboratories in 61 countries. Eurofins companies offer a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products.
In 2022, Eurofins generated total revenues of EUR 6.7 billion, and has been among the best performing stocks in Europe over the past 20 years.
